Title: Novel anti-inflammatory agents based on pyrazole based dimeric compounds; design, synthesis, docking and in vivo activity
| dc.contributor.author | Ashish Kumar Tewari | |
| dc.contributor.author | Priyanka Srivastava | |
| dc.contributor.author | Ved Prakash Singh | |
| dc.contributor.author | Amit Singh | |
| dc.contributor.author | Raj Kumar Goel | |
| dc.contributor.author | Chethampadi Gopi Mohan | |
| dc.date.accessioned | 2026-02-07T04:59:11Z | |
| dc.date.issued | 2010 | |
| dc.description.abstract | Series of pyrazole ester prodrugs analogues have been synthesized and found to contain highly potent inhibitors of the cyclooxygenase-2 (COX-2) enzyme. The paper describes synthesis of the target pyrazole analogues. The structure of the synthesized mutual ester prodrugs (6-8c) were confirmed by 1H-, 13C-NMR mass spectroscopy (MS) and their purity were ascertained by TLC and elemental analyses. The biological in vivo evaluation of these compounds in experimental models (carrageenan-induced oedema) proved the presence of anti-inflammatory activity. Docking studies into the catalytic site of COX-2 were used to identify potential anti-inflammatory lead compounds. One lead derivative was chosen endowed with good binding energies. © 2010 Pharmaceutical Society of Japan. | |
| dc.identifier.doi | 10.1248/cpb.58.634 | |
| dc.identifier.issn | 13475223 | |
| dc.identifier.uri | https://doi.org/10.1248/cpb.58.634 | |
| dc.identifier.uri | https://dl.bhu.ac.in/bhuir/handle/123456789/21769 | |
| dc.subject | Cyclooxygenase | |
| dc.subject | Docking | |
| dc.subject | NMR | |
| dc.subject | Prodrug | |
| dc.subject | Pyrazole | |
| dc.title | Novel anti-inflammatory agents based on pyrazole based dimeric compounds; design, synthesis, docking and in vivo activity | |
| dc.type | Publication | |
| dspace.entity.type | Article |
